About the Journal

   Journal Information

 Journal Title: Ahmar Metastasis Health Journal

 Initials: AMHJ

 Abbreviation: Ahmar Metastasis Heal.  J.

 Editor in Chief: Taufik Anwar

 Managing Editor: Kadar Ramadhan

 DOI : prefix 10.53770/amhj

 p-ISSN:  2797-4952 (Online) | 2797-6483  (Print)

 Language: Indonesia or English 

 Frequency: Four issues per year: June, September, December and March

 Publisher: Yayasan Ahmad Mansyur Nasirah

 Indexing: DOAJ | SINTA 5 | Dimensions | GARUDA | Google Scholar 

 Visitor: View Visitors AMHJ

 Focus and Scope:

  • Medicine: Public Health, Environmental and Occupational Health.
  • Pharmacology, Toxicology, and Pharmaceutics: Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

 Type of Articles:

  • Original Research: Studies presenting new and original findings in public health.
  • Review Papers: Comprehensive analyses of existing research on specific public health topics.
  • Case Reports: Detailed reports of individual or group cases providing unique insights.
  • Case Studies: In-depth examinations of specific public health scenarios or interventions.
  • Systematic Reviews: Structured reviews that follow a specific methodology to synthesize existing research.
  • Meta-Analyses: Quantitative analyses that combine data from multiple studies to derive overall conclusions.

Please note that we do not publish standalone survey results. Submissions should include a clear research hypothesis and conclusive findings. Each submission should uphold the highest standards of ethical research and contribute to advancing knowledge and practice in public health.

 

Ahmar Metastasis Health Journal (AMHJ), with registered number ISSN 2797-6483 (Print), 2797-4952 (Online) managed by the AHMAR Foundation, published by Yayasan Ahmad Mansyur Nasirah, which is a scientific forum for publishing articles on research activities in health fields such as Medicine, namely Public Health, Environmental and Occupational Health and Pharmacology, Toxicology, and Pharmaceutics, namely Pharmacology, Toxicology and Pharmaceutics (miscellaneous). The journal was first published in June 2021 and subsequently published four times a year, in June, September, December and March. Every article that goes to the editorial staff will be selected through Initial Review processes by the Editorial Board. Then, the articles will be sent to the peer reviewer and will go to the next selection. After that, the articles will be returned to the authors to revised. These processes take three months for a maximum time. In each manuscript, peer reviewers will be rated from the substantial and technical aspects. The final decision of article acceptance will be made by Editors according to Reviewer's comments. 

Ahmar Metastasis Health Journal (AMHJ) is a National Journal accredited with rank 5 [S5] by the Director General of Higher Education, Research and Technology, with Decree No. 152/E/KPT/2023; Title of Decree: Decree of the Director General of Higher Education, Research and Technology, Ministry of Education, Culture, Research and Technology of the Republic of Indonesia on the Accreditation Rating of Scientific Journals Period II in 2023 Date of Decree: 25 September 2023.

Current Issue

Vol. 4 No. 4 (2025): Ahmar Metastasis Health Journal
View Vol. 4 No. 4 (2025): Ahmar Metastasis Health Journal

This issue has been available online since March 31st, 2025. All articles in this issue were authored/co-authored by 24 authors from 5 countries (Indonesia, South Africa, Thailand, Libya and United Kingdom).

DOI: https://doi.org/10.53770/amhj.v4i4
Published: 2025-03-10

Original Research

View All Issues